Airway diseases
Interstitial lung diseases
Respiratory critical care
Oral presentation
Lung function and risk factors associated with obstructive lung diseases
Methods :
Respiratory intensive care, Public health, Physiology, Pulmonary function testing, Epidemiology
11:15
Lung function trajectories based on annual measurements for 10 years in adults with airway obstruction
H. Backman(Lulea, Sweden)
COI
1
11:20
Multi-ancestry genetic risk score for lung function from meta-analysis of genome-wide association studies in 580,869 individuals from five ancestry groups
N. Shrine(Leicester, United Kingdom)
COI
2
11:25
Prevalence and risk factors for small airways obstruction: Results from the Burden of Obstructive Lung Disease (BOLD) study.
B. Knox-Brown(NEWMARKET, United Kingdom)
COI
3
11:30
Race-adjusted lung function increases inequities in diagnosis and prognosis and should be abandoned
M. Ekström(Lund, Sweden)
COI
4
11:35
Plasma IgE and risk of exacerbation and mortality in COPD in the general population
Y. Çolak(Espergærde, Denmark)
COI
5
11:40
Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent post-diagnosis COPD exacerbations and mortality: a UK routine health care data study
H. Whittaker(London, United Kingdom)
COI
6
11:45
COVID-19 real-world data (RWD) insights regarding exacerbations and serum Eosinophil levels in Asthma and Chronic Obstructive Pulmonary Disease (COPD).
M. Cushion(Biggleswade, United Kingdom)
COI
7
11:50
Lung development genes, adult lung function and cardiovascular comorbidities
M. Talaei Pashiri(London, United Kingdom)
COI
8
11:55
Factors associated with specific causes of death in a primary care COPD population in England
H. Whittaker(London, United Kingdom)
COI
9
12:00
Late Breaking Abstract - Beyond direct costs: Individual and societal burden of asthma in young adults
K. Håkansson(Copenhagen V, Denmark)
COI
10
12:05
Discussion
11
OA3746
. . .
